{"id":964556,"date":"2026-05-19T08:22:24","date_gmt":"2026-05-19T12:22:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/"},"modified":"2026-05-19T08:22:24","modified_gmt":"2026-05-19T12:22:24","slug":"cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/","title":{"rendered":"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)<\/b><\/p>\n<p class=\"bwalignc\"><i>\u2014 Proven biopharmaceutical executive to lead commercial strategy as Cosette scales its branded pharmaceutical platform and advances its next phase of growth \u2014<\/i><\/p>\n<p>BRIDGEWATER, N.J.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nCosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the company\u2019s executive leadership team as it continues to advance its ambitions in specialty pharmaceuticals and expand its commercial platform and portfolio.<\/p>\n<p>\nIn this new role, David will oversee all branded commercial functions \u2013 including sales, marketing, market access, commercial operations, analytics, and portfolio strategy. He will be responsible for driving performance across Cosette\u2019s marketed portfolio of 21 brands, supporting the integration and growth of acquired assets, and ensuring strong alignment between commercial execution and the company\u2019s broader strategic and financial objectives.<\/p>\n<p>\n\u201cDavid\u2019s appointment reflects Cosette\u2019s continued investment in the commercial capabilities required to support the next level of growth,\u201d said Apurva Saraf, President and CEO of Cosette Pharmaceuticals. \u201cHis deep expertise in commercial strategy, market access, portfolio management, and P&amp;L leadership will be valuable as we continue to strengthen our branded portfolio and integrate new assets.\u201d<\/p>\n<p>\nDavid brings more than 25 years of commercial and enterprise leadership experience across oncology, rare disease and gene therapy in specialty pharmaceuticals markets. Most recently, David served as Vice President, Business Unit Head, US Oncology at Ferring Pharmaceuticals, where he held full U.S. P&amp;L ownership responsibility. He also previously served as Franchise General Manager at Melinta Therapeutics and spent 17 years at Merck &amp; Co. \/ Schering-Plough in progressive global, U.S., and regional commercial leadership roles.<\/p>\n<p>\n\u201cI am proud to join Cosette, an organization that has built a differentiated platform with brands that help patients live better lives,\u201d David shared. \u201cI am excited to join a leadership team that will take Cosette\u2019s branded portfolio to the next phase of corporate growth by maximizing current and acquired assets, expanding patient access to important medicines, and alleviating the burden and suffering of patients and their families.\u201d<\/p>\n<p>\nDavid earned his Master of Business Administration and Bachelor of Science in Finance from Seton Hall University\u2019s W. Paul Stillman School of Business. He also served as a board member of Enhanced HealthCare Solutions.<\/p>\n<p><b>About Cosette Pharmaceuticals<br \/>\n<br \/><\/b>Cosette Pharmaceuticals, Inc. is a U.S.-based, leading specialty pharmaceutical company providing some of the most trusted and well-known brands in medicine \u2014 developing and delivering products that make a difference in patients\u2019 lives. Cosette\u2019s strong growth has been driven by its best-in-class marketing, promotion, and strategic distribution capabilities, enabling the company to scale efficiently while continuing to invest in high-quality, patient-centered therapies. Cosette has corporate headquarters in Bridgewater, New Jersey and is supported by 350+ dedicated team members across all functional areas. Cosette is backed by Avista Healthcare Partners, a healthcare focused private equity firm, and funds managed by Hamilton Lane, a private markets investment management firm (Nasdaq: HLNE). For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cosettepharma.com&amp;esheet=54538170&amp;newsitemid=20260519485713&amp;lan=en-US&amp;anchor=www.cosettepharma.com&amp;index=1&amp;md5=6f0f6b4d3a0ba8e91c37fe828ef9fbf6\">www.cosettepharma.com<\/a> or follow Cosette on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fcosette-pharmaceuticals-inc&amp;esheet=54538170&amp;newsitemid=20260519485713&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=2&amp;md5=8ab82097b99dac81a9685013ef5e0bf1\">LinkedIn<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260519485713r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260519485713\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260519485713\/en\/<\/a><\/span><\/p>\n<p><b>Media:<br \/>\n<\/b><br \/><a rel=\"nofollow\" href=\"mailto:media@cosettepharma.com\">media@cosettepharma.com<\/a><\/p>\n<p><b>Business Development:<br \/>\n<\/b><br \/><a rel=\"nofollow\" href=\"mailto:bd@cosettepharma.com\">bd@cosettepharma.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> New Jersey United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology General Health Pharmaceutical Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260519485713\/en\/1464250\/3\/cosette_logomark_color_1800px.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) \u2014 Proven biopharmaceutical executive to lead commercial strategy as Cosette scales its branded pharmaceutical platform and advances its next phase of growth \u2014 BRIDGEWATER, N.J.&#8211;(BUSINESS WIRE)&#8211; Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the company\u2019s executive leadership team as it continues to advance its ambitions in specialty pharmaceuticals and expand its commercial platform and portfolio. In this new role, David will oversee all branded commercial functions \u2013 including sales, marketing, market access, commercial operations, analytics, and portfolio strategy. He will be responsible for driving performance across Cosette\u2019s marketed portfolio of 21 brands, supporting the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-964556","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) \u2014 Proven biopharmaceutical executive to lead commercial strategy as Cosette scales its branded pharmaceutical platform and advances its next phase of growth \u2014 BRIDGEWATER, N.J.&#8211;(BUSINESS WIRE)&#8211; Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the company\u2019s executive leadership team as it continues to advance its ambitions in specialty pharmaceuticals and expand its commercial platform and portfolio. In this new role, David will oversee all branded commercial functions \u2013 including sales, marketing, market access, commercial operations, analytics, and portfolio strategy. He will be responsible for driving performance across Cosette\u2019s marketed portfolio of 21 brands, supporting the &hellip; Continue reading &quot;Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-19T12:22:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260519485713r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)\",\"datePublished\":\"2026-05-19T12:22:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/\"},\"wordCount\":560,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260519485713r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/\",\"name\":\"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260519485713r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-05-19T12:22:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260519485713r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260519485713r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/","og_locale":"en_US","og_type":"article","og_title":"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) - Market Newsdesk","og_description":"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) \u2014 Proven biopharmaceutical executive to lead commercial strategy as Cosette scales its branded pharmaceutical platform and advances its next phase of growth \u2014 BRIDGEWATER, N.J.&#8211;(BUSINESS WIRE)&#8211; Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the company\u2019s executive leadership team as it continues to advance its ambitions in specialty pharmaceuticals and expand its commercial platform and portfolio. In this new role, David will oversee all branded commercial functions \u2013 including sales, marketing, market access, commercial operations, analytics, and portfolio strategy. He will be responsible for driving performance across Cosette\u2019s marketed portfolio of 21 brands, supporting the &hellip; Continue reading \"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-19T12:22:24+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260519485713r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)","datePublished":"2026-05-19T12:22:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/"},"wordCount":560,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260519485713r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/","name":"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260519485713r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-05-19T12:22:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260519485713r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260519485713r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-appoints-david-bell-as-chief-commercial-officer-brands\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/964556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=964556"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/964556\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=964556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=964556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=964556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}